经尿道1470nm激光汽化与经尿道电切术治疗前列腺增生疗效及安全性的比较研究

Comparative study on efficacy and safety of transurethral 1470nm laser vaporization and transurethral resection in the treatment of benign prostatic hyperplasia

目的探讨经尿道1470 nm激光前列腺汽化与电切术的疗效及安全性。方法将110例前列腺增生(BPH)患者分为两组,激光组60例采用1470 nm激光治疗,电切组50例经尿道电切(TURP)治疗,比较两组的疗效及安全性。结果激光组手术后最大尿流率(Qmax)、手术时间、术中出血量、术后膀胱冲洗时间、国际前列腺症状评分(IPSS)、留置尿管时间均优于电切组,差异均有统计学意义(均P<0.05)。结论经尿道1470 nm激光汽化治疗前列腺增生较TURP方法更具优势,可有效改善患者前列腺增生引起下尿路梗阻症状,使患者受益。

Objective To explore efficacy and safety of transurethral 1470 nm laser vaporization and transurethral resection in the treatment of benign prostatic hyperplasia(BPH). Methods 110 cases of BPH in our hospital from Aug. 2015 to Aug. 2017 were divided into the laser group and TURP group, 60 cases in the laser group were treated with 1470 nm laser and 50 cases in TURP group were underwent transurethral resection. The efficacy and safety were compared in two groups. Results The Qmax, operation time, intraoperative blood loss, postoperative bladder washing time,international prostate symptom score(IPSS), indwelling catheter time of the laser group were better than that of the TURP group, and the difference were statistically significant(all P<0.05). Conclusion Transurethral 1470 nm laser vaporization for the BPH is superior to TURP, which can effectively improve the symptoms of lower urinary tract obstruction of BPH and benefit patients.